Delivery Order SPE2DB20D2104-SPE2DB25FNANM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,231.86 to AmerisourceBergen Drug Corp for the supply of Aspirin-Dipyridamole Extended Release 25-200 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price delivery order was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,051.40 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for ultimate completion on July 22, 2025, with performance taking place at the vendor's Conshohocken facility. The award was competitively procured with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $1,250.47 from the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by September 12, 2025, with performance taking place at the vendor's corporate office in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $39,775.72 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, designated as a non-set-aside competitive award, is scheduled for completion by July 22, 2025, and represents a child award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,068.48 on September 17, 2025, by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 18, 2025, and represents a child contract under a larger indefinite delivery vehicle. The award carries no set-aside designation and will be performed at the...
- On August 8, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,180.23 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price contract is scheduled for completion by August 29, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order was competitively awarded with no set-aside...
- On August 29, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,792.39 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,152.00 from the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. The award is structured as a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The contract's ultimate completion date is September 16, 2025, and performance will be executed at the vendor's Conshohocken...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,315.38 by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. This firm fixed-price contract, which is a child order under a larger indefinite delivery vehicle, represents a non-competitive award with an ultimate completion date of August 28, 2025. The contract will be performed at the company's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,590.02 on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price contract, issued by the Defense Logistics Agency's Medical Supply Chain, represents a non-set-aside competitive award. The delivery order is performed at the awardee's corporate office location in Conshohocken, Pennsylvania, and follows the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNANMDelivery Order
On September 16, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,157.03 to AmerisourceBergen Drug Corp for Aspirin-Dipyridamole ER 25-200 mg tablets in units of 60 supplied through a firm fixed-price contract. The award is being performed in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order represents a non-set-aside competitive award with an ultimate completion date of September 17, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, provides comprehensive medical supply support to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/16/25 |